Company intelligence / Profile preview

FormuRx Pharmaceuticals

Taipei, Taipei City, Taiwanformurx.com ↗

Ownership: Private
Employees: ~3
Development stage: Preclinical

Overview

FormuRx Pharmaceuticals develops advanced drug delivery systems and high-barrier dosage forms, integrating proprietary technologies to address unmet clinical needs. The company has been recognized as a top startup for investment potential but does not have disclosed clinical trial results or late-stage assets[2].

Therapeutic areas: Other
Modalities: Drug delivery systems (specific therapeutic modalities such as small molecules, mAbs, etc. not explicitly listed; focus appears to be on advanced dosage forms and drug delivery[1][2])
Industry: Biotech

Partnerships

None specifically mentioned in public sources.

Beyond the preview

Go deeper on FormuRx Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FormuRx Pharmaceuticals.

Explore the full profile